| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 04/26/2011 | CA2386023C Mucosal dtpa vaccines |
| 04/26/2011 | CA2371109C Improved pharmaceutical formulations |
| 04/26/2011 | CA2359945C Inhibitors of crystallization in a solid dispersion |
| 04/26/2011 | CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 04/26/2011 | CA2341358C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/26/2011 | CA2289009C Multivalent vaccine composition with mixed carrier |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/21/2011 | WO2011047390A2 Heterocyclic benzoxazole compositions as inhibitors of hepatitis c virus |
| 04/21/2011 | WO2011047323A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047320A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047319A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047173A2 Pharmaceutical compositions for oral administration |
| 04/21/2011 | WO2011047048A1 Combination therapy treatment for viral infections |
| 04/21/2011 | WO2011046996A2 Consensus sequence for influenza a virus |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046946A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 04/21/2011 | WO2011046905A2 Pharmaceutical compositions |
| 04/21/2011 | WO2011046901A2 Broad spectrum antiviral and methods of use |
| 04/21/2011 | WO2011046873A1 Hiv integrase inhibitors |
| 04/21/2011 | WO2011046811A1 Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor |
| 04/21/2011 | WO2011046623A2 Hiv-1 antibodies |
| 04/21/2011 | WO2011046303A2 Novel method for preparing entecavir and intermediate used therein |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046193A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
| 04/21/2011 | WO2011046160A1 Method for screening of substance capable of preventing virus infection, and agent for preventing virus infection |
| 04/21/2011 | WO2011046057A1 Novel sugar chain compound containing sialyllactosamine-type or sialyl lewis x-type sialic acid and fucose |
| 04/21/2011 | WO2011045682A2 Active agent containing polymer network delivery composition and articles using the same |
| 04/21/2011 | WO2011045681A2 Carbohydrate entrapped active agent delivery composition and articles using the same |
| 04/21/2011 | WO2011045594A1 Novel macrocycles and methods for their production |
| 04/21/2011 | WO2011045593A1 Novel macrocyles and methods for their production |
| 04/21/2011 | WO2011045557A1 Compositions of botanical extracts and their use |
| 04/21/2011 | WO2011045471A1 Compositions and methods and uses related thereto |
| 04/21/2011 | WO2011045330A1 Macrocyclic integrase inhibitors |
| 04/21/2011 | WO2011045079A1 Hepatitis b virus specific human antibodies |
| 04/21/2011 | WO2011044746A1 Bamboo or wood vinegar solution, preparation method and use thereof |
| 04/21/2011 | WO2011044737A1 Use of cyclophosphamide for treating condyloma acuminata |
| 04/21/2011 | WO2011011725A3 Use of toxoplasma and derived compositions to prevent or treat microbial infections |
| 04/21/2011 | WO2010151476A3 Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate |
| 04/21/2011 | WO2010150281A3 Novel azabicyclohexanes |
| 04/21/2011 | WO2010144231A3 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/21/2011 | WO2010143075A3 Silver hydrosol, dental applications and other uses thereof |
| 04/21/2011 | WO2010141511A3 Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| 04/21/2011 | WO2010129457A3 Vaccines against tularemia |
| 04/21/2011 | WO2010114629A9 Formulation |
| 04/21/2011 | WO2010027501A9 Anti-lipid antibodies |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | WO2008104893A3 Nucleoside derivatives useful for the treatment or prevention of viral infections and methods of use thereof |
| 04/21/2011 | WO2008099284A3 Hiv combination vaccine and prime boost method |
| 04/21/2011 | WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092600 Pharmaceutical compositions comprising aminocyclohexane derivatives |
| 04/21/2011 | US20110092597 Method for treating herpes virus infection |
| 04/21/2011 | US20110092588 Lactone formulations and method of use |
| 04/21/2011 | US20110092584 Therapeutic use of quinonoid derivatives of cannabinoids |
| 04/21/2011 | US20110092578 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species |
| 04/21/2011 | US20110092557 Neuraminidase Inhibitors And Compositions And Methods Related Thereto |
| 04/21/2011 | US20110092549 Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone |
| 04/21/2011 | US20110092543 Wound And Mucosa Antiseptic Based on Bispyridiniumalkanes |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092536 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 04/21/2011 | US20110092521 Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases |
| 04/21/2011 | US20110092499 N-containing heterocyclic compounds |
| 04/21/2011 | US20110092495 Compounds for the treatment of multi-drug resistant bacterial infections |
| 04/21/2011 | US20110092494 Tricyclic Tetrahydroquinoline Antibacterial Agents |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092488 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections |
| 04/21/2011 | US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092477 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 04/21/2011 | US20110092467 7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds |
| 04/21/2011 | US20110092460 Cyclopropyl polymerase inhibitors |
| 04/21/2011 | US20110092458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases |
| 04/21/2011 | US20110092454 Methods For Treating Mycoplasma Related Conditions In Livestock |
| 04/21/2011 | US20110092451 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110092414 Composition for treating virus infection disease comprising jab1 |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091577 Drug release coatings on calcuim phosphate and uses thereof |
| 04/21/2011 | US20110091571 Method of controlling the propagation of mrsa, staph and other infections that colonize in the nose |
| 04/21/2011 | US20110091570 Compositions and Devices for Antisepsis and Anticoagulation |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091557 Composite material |
| 04/21/2011 | US20110091556 Antimicrobial compositions and methods of use |
| 04/21/2011 | US20110091555 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders. |
| 04/21/2011 | US20110091553 Method for producing microcapsules using solid fat |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091523 Cochleate compositions directed against expression of proteins |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091500 Inactivated Live-Attenuated Bluetongue Virus Vaccine |